Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

NCT05891080 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Stage III Non-small Cell Lung Cancer

Interventions

DRUG: Toripalimab
DRUG: JS004
DRUG: Pemetrexed
DRUG: Nab-paclitaxel
DRUG: Carboplatin
PROCEDURE: Surgery

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China